Literature DB >> 20232903

Growth of itraconazole nanofibers in supersaturated simulated intestinal fluid.

Randy Mellaerts1, Alexander Aerts, Tom P Caremans, Jan Vermant, Guy Van den Mooter, Johan A Martens, Patrick Augustijns.   

Abstract

Many drug compounds have limited solubility in water. To enhance the oral bioavailability of such compounds, pharmaceutical formulations target the creation of a supersaturated solution. Release of the compound from ordered mesoporous silica carrier is such a means for reaching supersaturation. Little is known about the evolution of supersaturated intestinal media. The present study reveals the phase transitions of the poorly water-soluble drug itraconazole in simulated intestinal fluid under conditions corresponding to supersaturation. Electron spin resonance of n-doxylstearic acid spin probes evidenced that during supersaturation itraconazole is solubilized inside the hydrophobic core of mixed micelles composed of lecithin and bile salt. Cryogenic transmission electron microscopy revealed that the supersaturated state of itraconazole provokes the formation of nanofibers with a uniform diameter of 12 nm. The nanofiber length determined via dynamic light scattering increases from 220 to 1480 nm after 30 and 90 min, respectively. Nanofibers drastically reduced transepithelial transport of itraconazole across a Caco-2 cell monolayer mimicking the gastrointestinal absorption. Based on our study, we suggest the existence of an optimum intraluminal itraconazole supersaturation at which itraconazole absorption is enhanced but formation of itraconazole nanofibers prevented.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232903     DOI: 10.1021/mp900300j

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  2 in total

Review 1.  Characterization of supersaturatable formulations for improved absorption of poorly soluble drugs.

Authors:  Ping Gao; Yi Shi
Journal:  AAPS J       Date:  2012-07-14       Impact factor: 4.009

2.  Inclusion complex of a new propiconazole derivative with β-cyclodextrin: NMR, ESI-MS and preliminary pharmacological studies.

Authors:  Narcisa Marangoci; Mihai Mares; Mihaela Silion; Adrian Fifere; Cristian Varganici; Alina Nicolescu; Calin Deleanu; Adina Coroaba; Mariana Pinteala; Bogdan C Simionescu
Journal:  Results Pharma Sci       Date:  2011-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.